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Infection with the apicomplexan protozoan parasite Toxoplasma gondii is an ongoing
public health problem. The parasite’s ability to invade and replicate within the host cell is
dependent on many effectors, such as dense granule proteins (GRAs) released from the
specialized organelle dense granules, into host cells. GRAs have emerged as important
determinants of T. gondii pathogenesis. However, the functions of some GRAs remain
undefined. In this study, we used CRISPR-Cas9 technique to disrupt 17 GRA genes
(GRA11, GRA12 bis, GRA13, GRA14, GRA20, GRA21, GRA28-31, GRA33-38, and
GRA40) in the virulent T. gondii RH strain. The CRISPR-Cas9 constructs abolished the
expression of the 17 GRA genes. Functional characterization of single 1GRA mutants
was achieved in vitro using cell-based plaque assay and egress assay, and in vivo
in BALB/c mice. Targeted deletion of these 17 GRA genes had no significant effect
neither on the in vitro growth and egress of the mutant strains from the host cells
nor on the parasite virulence in the mouse model of infection. Comparative analysis of
the transcriptomics data of the 17 GRA genes suggest that GRAs may serve different
functions in different genotypes and life cycle stages of the parasite. In sum, although
these 17 GRAs might not be essential for RH strain growth in vitro or virulence in
mice, they may have roles in other strains or parasite stages, which warrants further
investigations.
Keywords: Toxoplasma gondii, CRISPR-Cas9, dense granule proteins (GRAs), host-pathogen interaction,
virulence
INTRODUCTION
Toxoplasma gondii is an obligate intracellular apicomplexan protozoan parasite that can infect
all warm-blooded animals, mainly through oral and congenital infections (Tenter et al., 2000;
Elmore et al., 2010; Zhou et al., 2011). This parasite has a significant medical and socioeconomic
importance because it infects over two billion people worldwide. It is the causative agent of
Bai et al. Functional Characterization of Toxoplasma GRAs
toxoplasmosis, an important zoonotic disease that can cause
serious, even fatal health consequences in immunocompromised
individuals, such as AIDS patients and organ transplant
recipients (Liu et al., 2008; Xiao et al., 2010; Chemoh et al.,
2015). Infection in immunocompetent individuals are generally
asymptomatic, however the parasite persists as bradyzoites-
containing cysts in brain and muscle tissues for many years.
Primary infection in pregnant women can lead to fetus death,
deformity, abortion, and long-term damage of the eye and central
nervous system (Hill and Dubey, 2002).
The remarkable ability of T. gondii to invade and colonize
virtually all nucleated cells (Morisaki et al., 1995), and to adopt a
successful intracellular lifestyle depends partly on the sequential
secretion of effectors from the specialized secretory organelles
micronemes, rhoptries and dense granules (Håkansson et al.,
2001; Boothroyd and Dubremetz, 2008; Nadipuram et al., 2016).
T. gondii tachyzoites enter the host cells through an active
invasion mechanism and replicate within a membrane-bound
parasitophorous vacuole (PV) inside the surrogate host cell
cytoplasm (Coppens et al., 2006; Nam, 2009). After release from
the host cell, newly formed parasites invade new mammalian
host cells, and the replication cycle starts again. Most of the
dense granule proteins (GRAs) are destined to the PV and
parasitophorous vacuole membrane (PVM), and contribute to
the biogenesis andmaturation of the PV, and nutrient acquisition
(Mercier and Cesbron-Delauw, 2015).
Some GRA proteins have the ability to traffic to the host
cytoplasm or nucleus and interfere with host cell signaling
pathways. For example, GRA6 is a polymorphic dense granule
protein and activates the host transcription nuclear factor
of activated T cells 4 (NFAT4) in order to manipulate host
immune responses to maximize the parasite virulence in a strain-
specific manner (Ma et al., 2014). GRA15 is another strain-
specific effector that activates NF-κB pathway and induces IL-12
secretion in type II, but not type I or III genotypes. GRA15-
deficient type II strain cannot activate NF-κB pathway or induces
IL-12 secretion, henceGRA15-deficient type II strains grow faster
compared with wild-type strains (Rosowski et al., 2011). GRA16
and GRA24 also manipulate host gene expression and signaling
pathways (Bougdour et al., 2013; Braun et al., 2013). GRA17
mediates the transfer of small molecules between the host cell
and PV, and maintains the stability of the PV (Gold et al., 2015).
GRA7, GRA25, and GRA39 are also virulence factor and can
interfere with host cell signaling pathways (Alaganan et al., 2014;
Shastri et al., 2014; Nadipuram et al., 2016). GRA22 and GRA41
are involved in the parasite egress (Okada et al., 2013; LaFavers
et al., 2017).
Despite the wealth of information regarding T. gondii’s 40+
GRAs including sequence variation and expression of GRA
coding genes, and their roles in the infection process, the
contribution of many GRAs to the parasite growth and virulence
are still unclear. The CRISPR-Cas9 system provides a novel and
promising tool for editing T. gondii genes (Shen et al., 2014) and
the genome (Sidik et al., 2014; Wang et al., 2016a; Shen et al.,
2017). Using CRISPR-Cas9 to target T. gondii’s GRA genes may
ultimately offer a new approach to achieving functional cure to
toxoplasmosis. In this study, we used the CRISPR-Cas9 technique
to edit 17 GRA genes, namely GRA11, GRA12 bis, GRA13,
GRA14, GRA20, GRA21, GRA28-31, GRA33-38, and GRA40 in
the virulent T. gondii RH strain and examined the effects of gene
loss on the parasite’s ability to grow and exit from host cells in
vitro and to cause death in mice.
MATERIALS AND METHODS
Parasite and Cell Cultures
Tachyzoites of T. gondii RH strain (type I) were maintained
in vitro by passages in human foreskin fibroblast (HFF, ATCC,
Manassas, VA, USA). HFF cells were grown in 75-cm2 tissue
culture flasks containing Dulbecco’s Modified Eagle medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) and
10µg/ml gentamycin, at 37◦C under a 5% CO2 atmosphere.
To purify tachyzoites, infected HFF cells were lysed through
a 27-gauge needle and the tachyzoites were filtered using a
5µm pore size Millipore filter. The number of purified parasites
was counted using a hemocytometer under a phase-contrast
microscopy.
Construction of GRA Knockout T. gondii
Strains Using CRISPR-Cas9
GRA knockout strains were constructed by using CRISPR-Cas9
as previously described (Wang et al., 2016b). All plasmids,
primers, and gRNAs used in this study are listed in Table S1.
Briefly, sgRNA of each GRA was engineered into pSAG1::CAS9-
U6::sgUPRT by PCR using the Q5 Mutagenesis Kit (NEB).
Positive plasmid was extracted with Endo-Free Plasmid DNA
Mini Kit Protocols (OMEGA). The resistance cassettes (DHFR∗-
Ts) were amplified from the plasmid pUPRT-DHFR-D and
purified by agarose gel electrophoresis. About 40 µg positive
plasmids and 15 µg purified DHFR∗-Ts amplicons were co-
transfected into freshly harvested T. gondii RH tachyzoites by
electroporation. GRA-deficient tachyzoites were selected with
pyrimethamine and examined by PCR analysis. Stable clones
were confirmed by reverse transcription PCR (RT-PCR) by
comparison to WT strains. Total RNA was extracted from
tachyzoites of wild type (WT) or 1GRA mutant T. gondii
strains using TRIzol (Invitrogen). Reverse transcription was
performed using a PrimeScriptTM 1st Strand cDNA Synthesis
Kit (TaKaRa). The central region of each target gene cDNA was
amplified by RT-PCR using specific primers (see Table S1 in the
Supplemental Material).
Assessment of Parasite Growth Using
Plaque Assay
The growth rates of individualGRA-deficient andWTRH strains
were determined in HFF cells. Cells were grown to confluence
overnight in 6-well cell culture plates. The cells were then
infected with tachyzoites of 1GRA mutant and WT RH strains
(∼200 tachyzoites/well). Cells were incubated for 3 h to allow
the parasites to enter the host cells and were then washed twice
with sterile 1 × phosphate-buffered saline (PBS) to remove
unbound parasites, and freshmediumwas added. The plates were
incubated for 7 days at 37◦C in 5% CO2 environment. Then, the
culture medium was removed and infected HFF cells were fixed
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with 4% paraformaldehyde in PBS (pH 7.4) for 15min at ambient
temperature. Then, fixed cells were incubated with crystal violet
staining solution (2% [wt/vol] crystal violet, pH 7.4) for 10min
at ambient temperature. The size of plaques (i.e., areas in the cell
culture devoid of cells caused by the proliferating parasites) was
determined using inverted microscope as previously described
(Wang et al., 2017). This experiment was performed in triplicate
and the experiments were repeated three independent times.
Egress Assay
Asexual reproduction of T. gondii culminates with the egress
of the newly formed tachyzoites from the surrogate host cell
and subsequent parasite invasion into new host cells. Therefore,
parasite egress represents a very important event which is
indispensable for the parasite dissemination in the host body.
In order to determine the role of the GRAs in this important
process, we examined the effect of ionophore A23187modulating
Ca2+ homeostasis on the egress of the parasite from the host
cells. Briefly, HFF cells were incubated with 105 freshly harvested
T. gondii tachyzoites in 2ml culture medium for 3 h, followed
by washing twice with DMEM medium to remove the unbound
parasites. After 30–36 h of incubation, the wells were washed
twice with sterile PBS and 3µM calcium ionophore A23187
(Sigma) diluted in DMSO were added to the HFF cells. Live cell
FIGURE 1 | Overview of the CRISPR/Cas9 system and mutation analysis of Toxoplasma gondii dense granule proteins (GRA) genes. (A) Schematic representation of
CRISPR-Cas9 system used for disrupting the 17 GRAs genes by insertion of DHFR*-Ts cassette. (B,C) Diagnostic PCR shows GRA gene disruption in the mutants
compared to the wild-type strain. The KO-forward and KO-reverse primers were used to amplify the small fragment with 30 s extension time. (D,E) RT-PCR of mRNA
from parental RH (WT) and GRA-deficient strains, showing that the 17 GRA’s coding sequences were successfully disrupted. Marker denotes the DNA ladder.
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microscopy was used to monitor the timing of parasite egress
from HFF cells infected with the WT strain compared with HFF
cells infected with the mutant strains after addition of 3µM
calcium ionophore A23187.
Mouse Infection With GRA-Deficient
Strains
Specific-pathogen-free (SPF) inbred female BALB/c mice (8
weeks-old) were purchased from Center of Laboratory Animals,
Lanzhou Veterinary Research Institute, Lanzhou, China.
Mice (5 mice/cage) were housed in a SPF environment
within the animal care facility during the experiment.
Each mouse was injected intraperitoneally with 200
freshly harvested tachyzoites of GRA-deficient or WT RH
strain (10 mice per strain). The negative control mice
were injected with an equal amount PBS only. All mice
were monitored daily for the signs of illness and time of
death.
Bioinformatics Analysis of T. gondii Dense
Granule Proteins
Information on the genomic features (signal peptide, the
number of exons and transmembrane domains) and time-series
expression data of theGRA genes by the parasite cell cycle phases,
parasite life cycle stages (the oocyst, tachyzoite, and bradyzoites),
and the parasite genotypes were downloaded from ToxoDB
(http://ToxoDB.org; Gajria et al., 2007). GRA gene expression
data were processed using Robust Multiarray Average (RMA)
FIGURE 2 | Phenotypic characterization of GRA Knockouts in vitro. (A) Two hundred freshly harvested T. gondii tachyzoites of WT RH strains and GRA-deficient RH
strains per well were added to monolayers of HFF cells in 6-well culture plates. After 7 days, the number of plaques caused by the parasite’s proliferation was counted
using a microscope. No differences were detected in the number of plaques produced by wild-type (WT) RH strain vs. any of the GRA knockout strains.
(B) Representative images show the parasite egress of the parental WT RH strain and one of the GRA mutant RH strains (1gra11). Live cell imaging showed a similar
egress pattern between WT and all mutant parasites after addition of 3µM calcium ionophore A23187 at the indicated time points.
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algorithm of the Partek Genomics Suite package (Partek, Inc, St
Louis, MO, USA).
Statistical Analysis
Statistical analysis for the in vitro and in vivo experiments
was carried out using Graphpad Software package (GraphPad
Software, La Jolla, CA). All experiments in the present study
were conducted with at least 3 replicate and data were shown
as means ± standard deviations (SD). Significant differences
between means were determined by Student’s t-test. P-values
below 0.05 were considered significant.
RESULTS AND DISCUSSION
In this study, we assessed the impact of targeted disruption
of the individual 17 GRA genes (GRA11, GRA12 bis, GRA13,
GRA14, GRA20, GRA21, GRA28-31, GRA33-38, and GRA40) on
the ability of the virulent T. gondii RH tachyzoites to grow and
exit from the cultured HFF cells. We also examined the impact
of the disruption of GRA genes on the virulence of T. gondii in
BALB/c mice.
Generation of Single 1GRA Knockout RH
Strains
CRISPR-Cas9 technique was used to disrupt the GRA genes
in type I RH strain. We designed RNA-guided CRISPR-
Cas9 targeting T. gondii 17 GRA genes individually. The
larger pyrimethamine-resist fragment (DHFR∗-Ts) was designed
for inserting into the sgRNA-targeted coding region causing
frameshift mutation for GRA proteins (Figure 1A). Then, single
clones were identified by PCR, and small fragment (∼500 bp) was
not amplified in GRA-deficient strains due to the insertion of the
large DHFR∗-Ts fragment with short extension time, however it
was detected in the WT strain (Figures 1B,C). RT-PCR was used
to amplify cDNA products, reverse transcribed from mRNA, of
each GRA gene. Our result showed that CRISPR-Cas9 abolished
the expression of GRA genes in the transfected strains compared
with the WT strains (Figures 1D,E), indicating that the target
GRA genes were mutated at the Cas9 cleavage sites and that 17
1GRAmutant strains were successfully generated.
Deletion of GRA Genes Did Not Affect the
Parasite Growth and Egress
After confirming knockout by RT-PCR, we compared the plaque
formation in HFF monolayers grown in 6-well culture plates
7 days after infection with 200 tachyzoites of wild-type and
1GRA mutant strains by conventional crystal violet staining
and microscopic examination. As shown in Figure 2A, no
significant differences in the size of plaques were observed in
cells infected with wild-type compared to cells infected with
1GRA mutant strains (p = 0.1582). Next, we evaluated the role
of GRAs in the parasite egress. The infected HFF cells were
treated with 3µM calcium ionophore A23187 and the timing
of the parasite exit from the cells was monitored over 5min
(Figure 2B). No significant difference in the parasites egress was
observed between 1GRA mutants and WT strains. The 17 GRA
KO strains and the WT strains remained within the PV after
stimulation with DMSO. Calcium is a critical mediator of T.
gondii invasion and egress processes. The calcium ionophore
A23187 can stimulate the parasite to exit from the PV to the
extracellular space (Arrizabalaga et al., 2004; Caldas et al., 2010).
GRA41 can regulate the timing of egress and the sensitivity to
calcium (LaFavers et al., 2017). However, none of the 17 GRA
FIGURE 3 | Survival of BALB/c mice infected with Toxoplasma gondii wild-type or GRA-deficient RH strains. The mice were injected i.p., with 200 freshly harvested
tachyzoites of the indicated strains. Ten mice were used per parasite strain. The survival time was recorded daily until all the mice have died within 7–9 days post
challenge.
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mutant strains tested in the present study seem to be responsive
to the action of the A23187. In agreement with our results, a
previous study has shown that deletion of 15 rhoptry organelle
proteins ROPs (ROP10, ROP11, ROP15, ROP20, ROP23, ROP31,
ROP32, ROP33, ROP34, ROP35, ROP36, ROP40, ROP41, ROP46,
and ROP47) did not suppress the parasite’s ability to grow in
HFF cells or alter its pathogenicity for BALB/c mice (Wang et al.,
2017). This lack of effect of GRA deletion on the phenotype
of single parasite mutants argues for possible redundancy of
function for GRAs.
GRA Deletion Did Not Alter the Parasite
Virulence in Mice
We tested whether deletion of GRA genes in T. gondii RH
strains would cause any changes in the parasite virulence. We
inoculated female BALB/c mice intraperitoneally with 200 T.
gondii tachyzoites (wild-type or mutants) and monitored the
mortality and signs of illness on a daily basis. All mice died
within 7–9 days (Figure 3), suggesting that the 17 GRA genes
tested in the present study might not contribute to the parasite
virulence during infection. Previous studies have shown that
some of dense granule proteins such as GRA25 may regulate
the production of CCL2 and CCL1 in macrophages and thus
affect virulence, which was different between Type II and Type III
strains (Shastri et al., 2014).GRA39 is also an important virulence
factor in Type II strains (Nadipuram et al., 2016). However, our
results did not show any significant differences between WT
and 1GRA mutant strains. The fact that 1GRA strains did not
display any reduction or loss of pathogenicity in mice suggests
that deletion of a single genemight not be enough to influence the
highly virulent RH strain in which the knockout was performed.
More research is required to elucidate the impact of individual
or multiple GRA gene deletion on the phenotype and virulence
of T. gondii strains. It is possible that these GRA genes have
roles in the pathogenesis of T. gondii, but in T. gondii strains
of other genotypes or in other hosts. Disruption of these GRAs
in avirulent and more physiologically relevant cystogenic strains
may allow the assessment of more subtle roles in the virulence,
alteration in cyst formation or tissue tropism.
Sequence and Expression Analyses of
GRAs in T. gondii
More than one-third of T. gondii mRNAs exhibit a tightly
regulated expression pattern, probably driven by the diverse
cell-cycle-dependent processes mediated by the parasite in the
course of infection (Behnke et al., 2010). We mapped the
transcriptomic data of the 17 GRAs available in ToxoDB and
found that the expression profile of the majority of GRAs do
not follow a particular cell cycle pattern, and that GRA11 and
GRA12 bis expression level was low (Figure 4A). Bioinformatics
features of GRAs, such as the number of exons, signal peptide
and transmembrane domains are summarized in Table 1. The
majority of the known GRAs include a signal peptide at the
N terminus and a single transmembrane domain in the C-
terminal part of the protein. We found that some GRAs encode
multi-exons (even eight) and a small amount of GRAs do not
have a signal peptide or a transmembrane domain. The signal
peptide plays an important role in protein targeting and protein
translocation in and eukaryotic cells and is considered as a
FIGURE 4 | The trend charts of the distinct expression profiles of Toxoplasma
gondii GRAs. (A) Time-series expression profile of 17 GRA genes of T. gondii
RH strain by cell cycle phases of the parasite as described by Behnke et al.
(2010). (B) Transcriptomic expression profiles of 17 GRA genes in Type I (RH
and GT1), Type II (Pru and ME49), and Type III (CTG and VEG) strains.
(C) Transcriptomic profiles of 17 GRA genes related to the parasite life cycle
stages (oocyst, tachyzoite and bradyzoite). Expression profile of 17 GRA
genes of the oocysts recovered from cat feces, at 0 day (unsporulated), 4 days
(4 day sporulated), and 10 days (10 day sporulated), tachyzoites grown for 2
days in HFF cells (2 day in vitro), bradyzoites grown in HFF cells for 4 days and
8 days (4 day in vitro and 8 day in vitro), and 21 days tissue cyst-containing
bradyzoites harvested from infected mouse brains (21 day in vivo). Each line
represents the expression value of the corresponding gene. The data were
obtained from ToxoDB (36 release) and the graph was generated using
GraphPad Prism version 5.0.
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TABLE 1 | Bioinformatics features of GRA proteins of Toxoplasma gondii.
Name Gene ID Product description Exons Phenotype
value
TMHMMa Predicted signal
peptide
Acute
infection b
Chronic
infection b
GRA11 TGGT1_212410 Dense granule protein
GRA11
1 ND Yes Yes 5.97 5.21
GRA12 bis TGGT1_275850 Dense granule protein
GRA12
3 1.31 No Yes 3.00 2.63
GRA13 TGGT1_237880 Hypothetical protein 1 0.76 Yes Yes 120.50 34.28
GRA14 TGGT1_239740 Dense granule protein
GRA14
1 2.00 No Yes 116.36 53.11
GRA20 TGGT1_200010 Hypothetical protein 2 2.54 No No 37.97 30.74
GRA21 TGGT1_241610 Hypothetical protein 2 ND No Yes 18.40 13.56
GRA28 TGGT1_231960 Putative omega secalin 3 1.48 No Yes 33.28 3.58
GRA29 TGGT1_269690 Hypothetical protein 1 1.54 Yes Yes 47.08 77.60
GRA30 TGGT1_232000 Hypothetical protein 2 2.29 Yes Yes 33.46 44.61
GRA31 TGGT1_220240 Hypothetical protein 1 0.90 Yes Yes 33.92 22.57
GRA33 TGGT1_247440 Hypothetical protein 1 1.72 Yes Yes 48.06 45.42
GRA34 TGGT1_203290 Hypothetical protein 1 2.26 No Yes 64.29 248.97
GRA35 TGGT1_226380 Hypothetical protein 1 1.98 Yes Yes 48.74 32.29
GRA36 TGGT1_213067 Hypothetical protein 1 −0.21 Yes Yes 83.85 24.24
GRA37 TGGT1_236890 Hypothetical protein 2 2.10 Yes No 60.01 34.21
GRA38 TGGT1_312420 Hypothetical protein 4 −1.15 No Yes 27.17 17.82
GRA40 TGGT1_219810 Hypothetical protein 7 0.69 Yes No 114.88 97.16
ND, Not determined.
aPrediction of transmembrane helices was performed using the TMHMM program version 2.0.
bGene expression levels of fragments per kilobase of exon model per million mapped reads (FPKM) at acute (10 days post infection) and chronic infection (28 days post infection).
Source: http://www.toxodb.org/toxo/ [accessed 26 July 2018].
feature of the GRA proteins that enter the secretory pathway
(Hakimi and Bougdour, 2015). Most of the previously identified
GRA proteins have been predicted to contain classical or non-
classical signal peptide, such as GRA1, GRA2, GRA6, GRA9,
GRA16, and GRA21, whereas other GRAs (GRA10, GRA15,
GRA20, and GRA22) did not (Mercier and Cesbron-Delauw,
2015). However, a few GRAs do not seem to depend on signal
peptide to enter the secretory pathway, such as GRA5, which
is secreted into the PV as a unique soluble protein and then
binds to the PVM (Gendrin et al., 2008). Some GRA proteins
lack the transmembrane domain, typically GRA19, GRA20, and
GRA21, and may interact with the PVM through protein-protein
interactions (Hsiao et al., 2013). Other GRAs (38, 39, and 40) lack
the transmembrane domains or other identifiable sequences for
membrane association, suggesting they are soluble protein of the
PV (Nadipuram et al., 2016). It is possible that GRAs that lack
signal peptide or transmembrane domain perform their roles by
as yet unknown mechanisms.
We next analyzed the transcriptomic levels of 17 GRAs in
different T. gondii genotypes (Type I, II, and III), and found
that GRA20 and GRA34 were significantly different among the
three genotypes (Figure 4B). This difference may be because
these two GRAs play different roles in different strains. Levels of
the transcriptomic expression of 17 GRA genes across T. gondii
developmental stages are presented (Figure 4C). Our analysis
showed that most GRAs are differentially expressed at different
life cycle stages, but GRA11 and GRA21. The expression of
some GRA genes can be specifically up- or down-regulated
during parasite development (Fritz et al., 2012). For instance, the
expression of GRA7 was significantly reduced in in vitro 4 day
bradyzoites compared to that in the in vitro 2 day tachyzoites
and then restored to near tachyzoite’s levels in the in vitro
21 day bradyzoites (Buchholz et al., 2011). The expression of
GRA4, GRA6, and GRA8 has been reported to be reduced or
even non-detectable in the bradyzoites (Ferguson, 2004). The
different expression levels of some GRAs in different life cycle
stages indicate that the roles played by GRAs may play parasite
stage-dependent.
CONCLUSION
GRAs play key roles in modulating host-parasite interactions,
such as parasite vacuole remodeling, nutrient uptake and
manipulation of host signaling pathways (Nadipuram et al.,
2016). In this study, 17 1GRA mutant T. gondii strains were
successfully generated using CRISPR-Cas9 technique. The role
of these 17 GRA genes in the pathogenicity of T. gondii RH
strain was investigated in vitro and in vivo. We report here that
no significant difference was detected between 1GRA knockouts
and wild-type RH strains. These findings indicate thatGRA genes
examined in this study are not absolutely essential for T. gondii
RH virulence, suggesting that other virulence factors may be
involved in these processes or that virulence of T. gondii is the
result of a multigene effect. We also investigated the patterns of
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gene expression and bioinformatics features of the 17 GRAs, by
parasite cell cycle phases, life cycle stages and genotypes. Results
indicated that the expression of GRAs can vary across life cycle
stages or genotypes of T. gondii. Functional analysis of these
GRAs in other parasite strains or life cycle forms is therefore of
high importance and may further elucidate the pathogenic role
of GRAs in T. gondii infection.
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